Intravenous immunoglobulin therapy in multiple sclerosis: Progress from remyelination in the Theiler's virus model to a randomised, doubleblind, placebo-controlled clinical trial

John H. Noseworthy, Peter C. O'Brien, Baziel G.M. Van Engelen, Moses Rodriguez

Research output: Contribution to journalArticle

31 Scopus citations

Abstract

No treatment has been found which reverses long-standing neurological dysfunction in patients with multiple sclerosis (MS). Observations in animal models of MS show that immunoglobulins directed against CNS components promote oligodendroglial proliferation and new myelin synthesis. Preliminary studies in inflammatory-demyelinating diseases of the human peripheral and central nervous system suggest that the repeated intravenous administration of polyclonal human immunoglobulin (IVIg) is sometimes followed by clinical improvement. A randomised, placebo-controlled, doubleblind, clinical trial was designed to test the hypothesis that repeated administration of IVIg will result in a meaningfiu degree of recovery of apparently irreversibly lost neurological function (weakness). A total of 76 patients with MS will participate in the study. These patients had developed a fixed, apparently permanent weakness that had not improved in the preceding four to 18 months. If effective, IVIg administration may benefit the large proportion of patients with MS who have active disease by enhancing the potential for myelin repair in the evolution of the inflammatory-demyelinating lesion.

Original languageEnglish (US)
Pages (from-to)11-14
Number of pages4
JournalJournal of Neurology, Neurosurgery and Psychiatry
Volume57
Issue numberSUPPL
DOIs
StatePublished - 1994

ASJC Scopus subject areas

  • Surgery
  • Clinical Neurology
  • Psychiatry and Mental health

Fingerprint Dive into the research topics of 'Intravenous immunoglobulin therapy in multiple sclerosis: Progress from remyelination in the Theiler's virus model to a randomised, doubleblind, placebo-controlled clinical trial'. Together they form a unique fingerprint.

  • Cite this